SINOMED(SH:688108) Zheng Quan Zhi Xing·2025-08-08 16:23Core Viewpoint - The stock of Sino Medical Technology Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price drop of 30% over two consecutive trading days on August 7 and August 8, 2025 [1][2]. Group 1: Abnormal Trading Fluctuation - The stock trading of Sino Medical on August 7 and August 8, 2025, showed a cumulative closing price drop of 30%, qualifying as an abnormal trading fluctuation according to the Shanghai Stock Exchange regulations [1][2]. - The company conducted a self-examination and confirmed that no significant media reports or market rumors could impact the stock price, and there are no undisclosed major information affecting the trading price [1][3]. Group 2: Company Disclosures - The company previously disclosed that its new drug-eluting stent system received conditional approval from the FDA on July 22, 2025, and a subsidiary's product received breakthrough medical device certification from the FDA on August 7, 2025 [1][3]. - The company has not identified any need to correct or supplement previously disclosed information, and its normal production and operation status remains unaffected [1][3][4]. Group 3: Shareholder and Control Information - The company confirmed that its controlling shareholders and actual controllers do not have any major matters that could influence the abnormal trading fluctuation, including significant asset restructuring or debt restructuring [2][3].